TCM Pharma ApS Financials, key figures and credit report
Gross profit 223.3 kDKK FY 2023 +40.5% vs 2022
EBIT 174.6 kDKK FY 2023 +275.9% vs 2022
Net debt 189.4 kDKK FY 2023 -81.3% vs 2022
Quick ratio 0.0 FY 2023 +0 vs 2022
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -16.58 | 66.69 | 458.27 | 158.89 | 223.31 |
| Employee benefit expenses | -93.62 | ||||
| Other operating expenses | -25.59 | ||||
| Total depreciation | - 106.08 | - 278.85 | - 283.43 | - 164.54 | -23.13 |
| EBIT | - 122.66 | - 212.16 | 174.83 | -99.27 | 174.59 |
| Other financial income | 1.27 | 1.57 | 0.00 | ||
| Other financial expenses | -13.91 | -42.75 | -41.22 | -65.23 | -37.87 |
| Pre-tax profit | - 135.30 | - 253.35 | 133.62 | - 164.50 | 136.72 |
| Income taxes | 21.46 | -22.52 | 1.15 | -0.34 | |
| Net earnings | - 113.84 | - 275.87 | 133.62 | - 163.36 | 136.38 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Land and waters | 482.74 | 479.12 | |||
| Machinery and equipment | 1 299.76 | 1 071.04 | 787.61 | 458.40 | 3.08 |
| Tangible assets total | 1 299.76 | 1 071.04 | 787.61 | 941.14 | 482.19 |
| Investments total | |||||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 468.69 | ||||
| Current amounts owed by group member comp. | 4.04 | 4.05 | 4.05 | ||
| Prepayments and accrued income | 2.19 | 2.58 | 2.58 | 0.36 | |
| Current other receivables | 14.16 | 4.16 | 4.22 | 0.03 | 12.91 |
| Current deferred tax assets | 22.52 | 1.15 | |||
| Short term receivables total | 42.91 | 10.78 | 479.54 | 1.54 | 12.91 |
| Cash and bank deposits | 1.39 | 0.09 | 17.72 | 0.10 | 8.11 |
| Cash and cash equivalents | 1.39 | 0.09 | 17.72 | 0.10 | 8.11 |
| Balance sheet total (assets) | 1 344.07 | 1 081.91 | 1 284.86 | 942.78 | 503.22 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 52.08 | 52.08 |
| Retained earnings | -8.39 | - 122.23 | - 398.10 | - 171.75 | - 135.11 |
| Profit of the financial year | - 113.84 | - 275.87 | 133.62 | - 163.36 | 136.38 |
| Shareholders equity total | -72.23 | - 348.10 | - 214.49 | - 283.03 | 53.35 |
| Non-current loans from credit institutions | 1 102.09 | 686.13 | 436.60 | 142.20 | |
| Non-current liabilities total | 1 102.09 | 686.13 | 436.60 | 142.20 | |
| Current loans from credit institutions | 83.18 | 249.60 | 249.60 | 189.60 | |
| Current trade creditors | 55.30 | 52.89 | 47.68 | 83.40 | 18.45 |
| Current owed to group member | 128.59 | 400.86 | 716.78 | 681.34 | 197.46 |
| Other non-interest bearing current liabilities | 47.14 | 40.53 | 48.69 | 129.27 | 233.95 |
| Current liabilities total | 314.21 | 743.88 | 1 062.74 | 1 083.61 | 449.87 |
| Balance sheet total (liabilities) | 1 344.07 | 1 081.91 | 1 284.86 | 942.78 | 503.22 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated